SCHEMBL2316356

SCHEMBL2316356

COc1ccc2c(c1)C(C=CC(=O)c1ccccc1)=CC(C)(C)CO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.48
NPC1 O15118 6/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
PKM P14618 1/20 0.48
KLF5 Q13887 1/20 0.48
MAPT P10636 7/20 0.48
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
BCHE P06276 3/20 0.47
CYP3A4 P08684 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
MAOB P27338 4/20 0.45
HSPD1 P10809 1/20 0.44
TNFRSF1A P19438 1/20 0.44
HSPE1 P61604 1/20 0.44
CYP1B1 Q16678 1/20 0.44
CDC25A P30304 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2316354 1.00 RAB9A (0.48) RAB9ANPC1MEN1KMT2APKM
SCHEMBL3596221 0.89 RAB9A (0.39) RAB9ANPC1MEN1KMT2APKM
SCHEMBL3596227 0.89 RAB9A (0.39) RAB9ANPC1MEN1KMT2APKM
SCHEMBL3596228 0.89 RAB9A (0.39) RAB9ANPC1MEN1KMT2APKM
SCHEMBL2317270 0.86 RAB9A (0.38) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL2317267 0.86 RAB9A (0.38) RAB9ANPC1MEN1KMT2AMAPT
Oxeglitazar SCHEMBL1547427 0.83 RXRA (0.41) RAB9ANPC1PKMMAPTALDH1A1
Oxeglitazar SCHEMBL1547425 0.83 RXRA (0.41) RAB9ANPC1PKMMAPTALDH1A1
Oxeglitazar SCHEMBL29372761 0.83 RXRA (0.41) RAB9ANPC1PKMMAPTALDH1A1
Oxeglitazar SCHEMBL3605899 0.83 RXRA (0.41) RAB9ANPC1PKMMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP claimed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP claimed
EP-1609786-B1 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids MERCK SANTE SAS (FR) 2011-08-03 EP disclosed
EP-1758876-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GmbH (DE) 2007-03-07 EP disclosed
WO-2006002721-A1 NEW 5-ALKENONE-3,3-DIMETHYL-BENZOXEPINES DERIVATIVES USEFUL FOR THE PREPARATION OF ANTIDIABETIC PENTADIENOIC ACIDS MERCK PATENT GMBH (DE) 2006-01-12 WO disclosed
EP-1609786-A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids Merck Sante (FR) 2005-12-28 EP disclosed